Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

To investigate predictors of cardiac morbidity in Valsartan treated high risk hypertensive patients with diabetes, new-onset diabetes and without diabetes : The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial

Trial Profile

To investigate predictors of cardiac morbidity in Valsartan treated high risk hypertensive patients with diabetes, new-onset diabetes and without diabetes : The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Valsartan (Primary) ; Amlodipine
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms VALUE
  • Most Recent Events

    • 14 Apr 2021 Results of post hoc analysis of value trial assessing the risk of cardiovascular events in mostly elderly high-risk hypertensive patients with type-2 DM participating in the valsartan antihypertensive long-term use evaluation trial, presented at the Joint Meeting of the European Society of Hypertension and International Society of Hypertension
    • 01 Apr 2019 Results published in the Blood Pressure
    • 11 Jun 2018 Results assessing blood pressure variability (n=14996) presented at the 28th European Meeting on Hypertension and Cardiovascular Protection.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top